Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
The global Follicle Stimulating Hormone market was valued at US$ 1244 million in 2020 and is expected to reach US$ 1504.9 million by the end of 2029, growing at a CAGR of 2.8% during 2021-2029.
This report focuses on Follicle Stimulating Hormone volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Follicle Stimulating Hormone market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Follicle Stimulating Hormone Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Recombinant FSH
Urinary FSH
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
By Region
North America
Europe
Poland
Asia-Pacific
Latin America
Middle East & Africa
By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
1 Follicle Stimulating Hormone Market Overview
1.1 Product Overview and Scope of Follicle Stimulating Hormone
1.2 Follicle Stimulating Hormone Segment by Type
1.2.1 Global Follicle Stimulating Hormone Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone Segment by Application
1.3.1 Global Follicle Stimulating Hormone Sales Comparison by Application: (2021-2029)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Follicle Stimulating Hormone Revenue 2016-2029
1.4.2 Global Follicle Stimulating Hormone Sales 2016-2029
1.4.3 Follicle Stimulating Hormone Market Size by Region: 2016 Versus 2021 Versus 2029
2 Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2016-2021)
2.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Follicle Stimulating Hormone Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Follicle Stimulating Hormone Manufacturing Sites, Area Served, Product Type
2.5 Follicle Stimulating Hormone Market Competitive Situation and Trends
2.5.1 Follicle Stimulating Hormone Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Follicle Stimulating Hormone Players Market Share by Revenue
2.5.3 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Follicle Stimulating Hormone Retrospective Market Scenario by Region
3.1 Global Follicle Stimulating Hormone Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Follicle Stimulating Hormone Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Follicle Stimulating Hormone Market Facts & Figures by Country
3.3.1 North America Follicle Stimulating Hormone Sales by Country
3.3.2 North America Follicle Stimulating Hormone Revenue by Country
3.4 Europe Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 Europe Follicle Stimulating Hormone Sales by Country
3.4.2 Europe Follicle Stimulating Hormone Revenue by Country
3.4.3 Poland
3.5 Asia Pacific Follicle Stimulating Hormone Market Facts & Figures by Region
3.5.1 Asia Pacific Follicle Stimulating Hormone Sales by Region
3.5.2 Asia Pacific Follicle Stimulating Hormone Revenue by Region
3.6 Latin America Follicle Stimulating Hormone Market Facts & Figures by Country
3.6.1 Latin America Follicle Stimulating Hormone Sales by Country
3.6.2 Latin America Follicle Stimulating Hormone Revenue by Country
3.7 Middle East and Africa Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Middle East and Africa Follicle Stimulating Hormone Sales by Country
3.7.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Country
4 Global Follicle Stimulating Hormone Historic Market Analysis by Type
4.1 Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
4.2 Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2021)
4.3 Global Follicle Stimulating Hormone Price by Type (2016-2021)
5 Global Follicle Stimulating Hormone Historic Market Analysis by Application
5.1 Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
5.2 Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2021)
5.3 Global Follicle Stimulating Hormone Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Corporation Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Corporation Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.2.4 MSD Follicle Stimulating Hormone Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 IBSA
6.3.1 IBSA Corporation Information
6.3.2 IBSA Description and Business Overview
6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
6.3.5 IBSA Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Corporation Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 Livzon
6.5.1 Livzon Corporation Information
6.5.2 Livzon Description and Business Overview
6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
6.5.5 Livzon Recent Developments/Updates
6.6 Techwell
6.6.1 Techwell Corporation Information
6.6.2 Techwell Description and Business Overview
6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
6.6.5 Techwell Recent Developments/Updates
6.7 GenSci
6.6.1 GenSci Corporation Information
6.6.2 GenSci Description and Business Overview
6.6.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GenSci Follicle Stimulating Hormone Product Portfolio
6.7.5 GenSci Recent Developments/Updates
6.8 Gedeon Richter
6.8.1 Gedeon Richter Corporation Information
6.8.2 Gedeon Richter Description and Business Overview
6.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
6.8.5 Gedeon Richter Recent Developments/Updates
6.9 Teva
6.9.1 Teva Corporation Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Teva Follicle Stimulating Hormone Product Portfolio
6.9.5 Teva Recent Developments/Updates
7 Follicle Stimulating Hormone Manufacturing Cost Analysis
7.1 Follicle Stimulating Hormone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Follicle Stimulating Hormone
7.4 Follicle Stimulating Hormone Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Follicle Stimulating Hormone Distributors List
8.3 Follicle Stimulating Hormone Customers
9 Follicle Stimulating Hormone Market Dynamics
9.1 Follicle Stimulating Hormone Industry Trends
9.2 Follicle Stimulating Hormone Growth Drivers
9.3 Follicle Stimulating Hormone Market Challenges
9.4 Follicle Stimulating Hormone Market Restraints
10 Global Market Forecast
10.1 Follicle Stimulating Hormone Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Follicle Stimulating Hormone by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Type (2022-2029)
10.2 Follicle Stimulating Hormone Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Follicle Stimulating Hormone by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Application (2022-2029)
10.3 Follicle Stimulating Hormone Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Follicle Stimulating Hormone by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Follicle Stimulating Hormone Sales (K Doses) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Follicle Stimulating Hormone Sales (K Doses) Comparison by Application (2021-2029)
Table 3. Global Follicle Stimulating Hormone Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Follicle Stimulating Hormone Covered in This Study
Table 5. Global Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Follicle Stimulating Hormone Manufacturing Sites and Area Served
Table 11. Manufacturers Follicle Stimulating Hormone Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle Stimulating Hormone as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 16. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 17. Global Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 19. North America Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 20. North America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 22. Europe Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 24. Europe Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
Table 30. Latin America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 32. Latin America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 38. Global Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 39. Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 40. Global Follicle Stimulating Hormone Revenue (Million US$) by Type (2016-2021)
Table 41. Global Follicle Stimulating Hormone Revenue Share by Type (2016-2021)
Table 42. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2016-2021)
Table 43. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2016-2021)
Table 44. Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 45. Global Follicle Stimulating Hormone Revenue (Million US$) by Application (2016-2021)
Table 46. Global Follicle Stimulating Hormone Revenue Share by Application (2016-2021)
Table 47. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2016-2021)
Table 48. Merck Serono Corporation Information
Table 49. Merck Serono Description and Business Overview
Table 50. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Merck Serono Follicle Stimulating Hormone Product
Table 52. Merck Serono Recent Developments/Updates
Table 53. MSD Corporation Information
Table 54. MSD Description and Business Overview
Table 55. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. MSD Follicle Stimulating Hormone Product
Table 57. MSD Recent Developments/Updates
Table 58. IBSA Corporation Information
Table 59. IBSA Description and Business Overview
Table 60. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. IBSA Follicle Stimulating Hormone Product
Table 62. IBSA Recent Developments/Updates
Table 63. Ferring Corporation Information
Table 64. Ferring Description and Business Overview
Table 65. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Ferring Follicle Stimulating Hormone Product
Table 67. Ferring Recent Developments/Updates
Table 68. Livzon Corporation Information
Table 69. Livzon Description and Business Overview
Table 70. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Livzon Follicle Stimulating Hormone Product
Table 72. Livzon Recent Developments/Updates
Table 73. Techwell Corporation Information
Table 74. Techwell Description and Business Overview
Table 75. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Techwell Follicle Stimulating Hormone Product
Table 77. Techwell Recent Developments/Updates
Table 78. GenSci Corporation Information
Table 79. GenSci Description and Business Overview
Table 80. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. GenSci Follicle Stimulating Hormone Product
Table 82. GenSci Recent Developments/Updates
Table 83. Gedeon Richter Corporation Information
Table 84. Gedeon Richter Description and Business Overview
Table 85. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Gedeon Richter Follicle Stimulating Hormone Product
Table 87. Gedeon Richter Recent Developments/Updates
Table 88. Teva Corporation Information
Table 89. Teva Description and Business Overview
Table 90. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Teva Follicle Stimulating Hormone Product
Table 92. Teva Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Follicle Stimulating Hormone Distributors List
Table 96. Follicle Stimulating Hormone Customers List
Table 97. Follicle Stimulating Hormone Market Trends
Table 98. Follicle Stimulating Hormone Growth Drivers
Table 99. Follicle Stimulating Hormone Market Challenges
Table 100. Follicle Stimulating Hormone Market Restraints
Table 101. Global Follicle Stimulating Hormone Sales Forecast by Type (2022-2029) & (K Doses)
Table 102. Global Follicle Stimulating Hormone Sales Market Share Forecast by Type (2022-2029)
Table 103. Global Follicle Stimulating Hormone Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 104. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2022-2029)
Table 105. Global Follicle Stimulating Hormone Sales Forecast by Application (2022-2029) & (K Doses)
Table 106. Global Follicle Stimulating Hormone Sales Market Share Forecast by Application (2022-2029)
Table 107. Global Follicle Stimulating Hormone Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 108. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2022-2029)
Table 109. Global Follicle Stimulating Hormone Sales Forecast by Region (2022-2029) & (K Doses)
Table 110. Global Follicle Stimulating Hormone Sales Market Share Forecast by Region (2022-2029)
Table 111. Global Follicle Stimulating Hormone Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 112. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2022-2029)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Follicle Stimulating Hormone
Figure 2. Global Follicle Stimulating Hormone Market Share by Type in 2020 & 2029
Figure 3. Recombinant FSH Product Picture
Figure 4. Urinary FSH Product Picture
Figure 5. Global Follicle Stimulating Hormone Market Share by Application in 2020 & 2029
Figure 6. Infertility Treatment
Figure 7. Assisted Reproductive Technology
Figure 8. Global Follicle Stimulating Hormone Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 9. Global Follicle Stimulating Hormone Market Size 2016-2029 (US$ Million)
Figure 10. Global Follicle Stimulating Hormone Sales 2016-2029 (K Doses)
Figure 11. Global Follicle Stimulating Hormone Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 12. Follicle Stimulating Hormone Sales Share by Manufacturers in 2020
Figure 13. Global Follicle Stimulating Hormone Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Follicle Stimulating Hormone Players: Market Share by Revenue in 2020
Figure 15. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Figure 17. Global Follicle Stimulating Hormone Sales Market Share by Region in 2020
Figure 18. Global Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
Figure 19. Global Follicle Stimulating Hormone Revenue Market Share by Region in 2020
Figure 20. Poland Follicle Stimulating Hormone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Sales Market Share of Follicle Stimulating Hormone by Type (2016-2021)
Figure 22. Sales Market Share of Follicle Stimulating Hormone by Application (2016-2021)
Figure 23. Sales Market Share of Follicle Stimulating Hormone by Application in 2020
Figure 24. Revenue Share of Follicle Stimulating Hormone by Application (2016-2021)
Figure 25. Revenue Share of Follicle Stimulating Hormone by Application in 2020
Figure 26. Manufacturing Cost Structure of Follicle Stimulating Hormone
Figure 27. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 28. Follicle Stimulating Hormone Industrial Chain Analysis
Figure 29. Channels of Distribution
Figure 30. Distributors Profiles
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
